Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 1
1973 1
1974 3
1975 3
1976 11
1977 9
1978 8
1979 25
1980 23
1981 36
1982 56
1983 56
1984 46
1985 47
1986 49
1987 68
1988 40
1989 51
1990 66
1991 57
1992 56
1993 48
1994 30
1995 54
1996 42
1997 35
1998 46
1999 42
2000 48
2001 42
2002 57
2003 55
2004 56
2005 42
2006 44
2007 54
2008 33
2009 35
2010 46
2011 61
2012 63
2013 56
2014 48
2015 48
2016 41
2017 39
2018 39
2019 45
2020 35
2021 46
2022 40
2023 25
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

2,003 results

Results by year

Filters applied: . Clear all
Page 1
17 beta-estradiol/levonorgestrel transdermal system.
Dando TM, Perry CM. Dando TM, et al. Treat Endocrinol. 2004;3(5):319-24. doi: 10.2165/00024677-200403050-00005. Treat Endocrinol. 2004. PMID: 15330679 Review.
The estradiol/levonorgestrel transdermal system was generally well tolerated. In two trials, application-site reactions were common in all treatment groups (estradiol/levonorgestrel, estradiol, and placebo)....
The estradiol/levonorgestrel transdermal system was generally well tolerated. In two trials, application-site reactions were c …
Venous Thromboembolic Risk of Estradiol Valerate-Dienogest Compared with Ethinyl Estradiol-Levonorgestrel Combined Oral Contraceptives.
Bauerfeind A, von Stockum S, Boehnke T, Heinemann K. Bauerfeind A, et al. Obstet Gynecol. 2024 Mar 1;143(3):431-434. doi: 10.1097/AOG.0000000000005509. Epub 2024 Jan 16. Obstet Gynecol. 2024. PMID: 38227942
This pooled analysis compared the risk of venous thromboembolism (VTE) associated with combined oral contraceptives (COCs) containing estradiol (E2) valerate-dienogest with those containing ethinyl E2-levonorgestrel. ...The pooled data set included 11,616 E2 valerat …
This pooled analysis compared the risk of venous thromboembolism (VTE) associated with combined oral contraceptives (COCs) containing est …
Extended regimen of a levonorgestrel/ethinyl estradiol transdermal delivery system: Predicted serum hormone levels using a population pharmacokinetic model.
Stanczyk FZ, Archer DF, Lohmer LRL, Pirone J, Previtera M, Korner P. Stanczyk FZ, et al. PLoS One. 2022 Dec 27;17(12):e0279640. doi: 10.1371/journal.pone.0279640. eCollection 2022. PLoS One. 2022. PMID: 36574387 Free PMC article. Clinical Trial.
OBJECTIVE: This study employed population pharmacokinetic (popPK) models to predict levonorgestrel (LNG) and ethinyl estradiol (EE) exposure after dosing with the transdermal contraceptive TWIRLA (LNG/EE TDS) as a 12-week extended regimen in a healthy female populat …
OBJECTIVE: This study employed population pharmacokinetic (popPK) models to predict levonorgestrel (LNG) and ethinyl estradiol …
An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome.
Freeman EW, Halbreich U, Grubb GS, Rapkin AJ, Skouby SO, Smith L, Mirkin S, Constantine GD. Freeman EW, et al. Contraception. 2012 May;85(5):437-45. doi: 10.1016/j.contraception.2011.09.010. Epub 2011 Dec 5. Contraception. 2012. PMID: 22152588 Review.
BACKGROUND: This article presents an overview of four studies that evaluated a continuous oral contraceptive (OC) containing levonorgestrel (90 mcg) and ethinyl estradiol (20 mcg; LNG/EE) for managing premenstrual dysphoric disorder (PMDD) and premenstrual syndrome …
BACKGROUND: This article presents an overview of four studies that evaluated a continuous oral contraceptive (OC) containing levonorgestr …
Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.
Lete I, Chabbert-Buffet N, Jamin C, Lello S, Lobo P, Nappi RE, Pintiaux A. Lete I, et al. Eur J Contracept Reprod Health Care. 2015;20(5):329-43. doi: 10.3109/13625187.2015.1050091. Epub 2015 May 26. Eur J Contracept Reprod Health Care. 2015. PMID: 26007631 Review.
In this study we compared two reference combined oral contraceptives (COCs) containing ethinylestradiol (EE)/levonorgestrel (LNG) and EE/drospirenone (DRSP) with COCs containing estradiol (E2) (estradiol valerate [E2V]/dienogest [DNG] and E2/nomegestrol aceta …
In this study we compared two reference combined oral contraceptives (COCs) containing ethinylestradiol (EE)/levonorgestrel (LNG) and …
Emergency contraception.
Dunn S, Guilbert É; SOCIAL SEXUAL ISSUES COMMITTEE. Dunn S, et al. J Obstet Gynaecol Can. 2012 Sep;34(9):870-878. doi: 10.1016/S1701-2163(16)35387-7. J Obstet Gynaecol Can. 2012. PMID: 22971457
OBJECTIVE: To review current knowledge about emergency contraception (EC), including available options, their modes of action, efficacy, safety, and the effective provision of EC within a practice setting. OPTIONS: The combined estradiol-levonorgestrel (Yuzpe regime …
OBJECTIVE: To review current knowledge about emergency contraception (EC), including available options, their modes of action, efficacy, saf …
Low-dose ethinylestradiol/levonorgestrel.
Dando TM, Curran MP. Dando TM, et al. Drugs. 2005;65(16):2299-306; discusion 2307-8. doi: 10.2165/00003495-200565160-00007. Drugs. 2005. PMID: 16266199 Review.
Low-dose ethinylestradiol/levonorgestrel 20 microg/100 microg is a combined oral contraceptive that prevents pregnancy primarily by inhibiting ovulation. ...Ethinylestradiol/levonorgestrel 20 microg/100 microg is well tolerated; adverse events were those commonly as …
Low-dose ethinylestradiol/levonorgestrel 20 microg/100 microg is a combined oral contraceptive that prevents pregnancy primarily by i …
Efficacy, safety, and tolerability of a levonorgestrel/ethinyl estradiol transdermal delivery system: Phase 3 clinical trial results.
Nelson AL, Kaunitz AM, Kroll R, Simon JA, Poindexter AN, Castaño PM, Ackerman RT, Flood L, Chiodo JA 3rd, Garner EI; SECURE Investigators. Nelson AL, et al. Contraception. 2021 Mar;103(3):137-143. doi: 10.1016/j.contraception.2020.11.011. Epub 2020 Nov 28. Contraception. 2021. PMID: 33259782 Free article. Clinical Trial.
OBJECTIVE: To assess the contraceptive efficacy, safety, and tolerability of a contraceptive transdermal delivery system, (TDS; TWIRLA(R)) containing levonorgestrel (LNG) and ethinyl estradiol (EE). STUDY DESIGN: This single-arm, open-label, multicenter, 1-year (13 …
OBJECTIVE: To assess the contraceptive efficacy, safety, and tolerability of a contraceptive transdermal delivery system, (TDS; TWIRLA(R)) c …
2,003 results